Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
My north star: We disclose—fast, fully, and on our terms. The “wait for more data” option is a mirage. It exposes the company to criminal liability under FDA adverse-event reporting rules, potential DOJ investigation, securities fraud charges, and derivative litigation that could destroy the firm.Read the full answer
As CEO, my overriding duty is to balance patient safety, legal/regulatory compliance, fiduciary responsibility, and long-term corporate survival. A 1-in-8,000 risk of liver failure is rare but severe, potentially fatal, and materially unexpected relative to the current label.Read the full answer